Somalogic, Incorporated

SomaLogic, Incorporated is a biotechnology company dedicated to transforming healthcare through advanced protein biomarker discovery and development. They specialize in developing and commercializing breakthrough proteomic technologies to improve the understanding of human health and enable personalized medicine approaches. With their expertise in large-scale proteomics and data science, SomaLogic provides solutions for a wide range of applications, including diagnostics, drug discovery, and clinical research. Their innovative technology platform, known as SOMAscan, enables the measurement of thousands of protein biomarkers simultaneously, leading to better insights into disease mechanisms, prediction of therapeutic response, and identification of new drug targets.